We are live on
!
Find out more
DA
Dillon & Associates Portfolio holdings
AUM
$726M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$357M
AUM Growth
+$28.8M
(+8.8%)
Cap. Flow
+$2.41M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
47.08%
Holding
70
New
3
Increased
33
Reduced
21
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.01M |
| 2 |
PayPal
PYPL
|
+$761K |
| 3 |
Meta Platforms (Facebook)
META
|
+$718K |
| 4 |
RTX Corp
RTX
|
+$517K |
| 5 |
Euronet Worldwide
EEFT
|
+$485K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$1.65M |
| 2 |
Johnson & Johnson
JNJ
|
+$984K |
| 3 |
FedEx
FDX
|
+$877K |
| 4 |
Cognizant
CTSH
|
+$355K |
| 5 |
CELG
Celgene Corp
CELG
|
+$263K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.59% |
| 2 | Healthcare | 19.26% |
| 3 | Communication Services | 10.89% |
| 4 | Financials | 10.34% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Adobe
ADBE
$99.5B
| $468K | 0.13% |
1,417
+463
| +49% | +$136K |
|
52
Coca-Cola
KO
$377B
| $441K | 0.12% |
8,027
+300
| +4% | +$16.1K |
|
53
Biogen
BIIB
$30B
| $431K | 0.12% |
1,451
-425
| -23% | -$118K |
|
54
Cisco
CSCO
$457B
| $416K | 0.12% |
8,665
-18
| -0.2% | -$837 |
|
55
Target
TGT
$65.6B
| $371K | 0.1% |
2,900
| – | – |
|
56
Bristol-Myers Squibb
BMY
$133B
| $364K | 0.1% |
+5,684
| New | +$326K |
|
57
Eaton
ETN
$161B
| $346K | 0.1% |
3,646
| – | – |
|
58
UnitedHealth
UNH
$376B
| $323K | 0.09% |
1,100
| – | – |
|
59
ExxonMobil
XOM
$644B
| $308K | 0.09% |
4,393
+426
| +11% | +$29.5K |
|
|
60
FedEx
FDX
$72.7B
| $306K | 0.09% |
2,025
-5,690
| -74% | -$877K |
|
61
Emerson Electric
EMR
$83.9B
| $297K | 0.08% |
3,907
-50
| -1% | -$3.6K |
|
62
Enbridge
ENB
$119B
| $281K | 0.08% |
7,025
| – | – |
|
63
Berkshire Hathaway Class B
BRK.B
$1.1T
| $234K | 0.07% |
1,034
| – | – |
|
64
NeoGenomics
NEO
$1.96B
| $232K | 0.06% |
+8,000
| New | +$191K |
|
65
AT&T
T
$159B
| $212K | 0.06% |
+7,200
| New | +$208K |
|
66
Imunon
IMNN
$6.68M
| $45K | 0.01% |
114
| – | – |
|
67
Rockwell Medical
RMTI
$28.4M
| $23K | 0.01% |
104
| – | – |
|
|
GCVRZ
68
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $9K | ﹤0.01% |
10,260
| – | – |
|
|
69
Cognizant
CTSH
$24.9B
| – | – |
-5,923
| Closed | -$355K |
|
|
CELG
70
DELISTED
Celgene Corp
CELG
| – | – |
-2,659
| Closed | -$263K |
|
Similar funds
TC
F
SDH
SCM
MWP
FAN
TFHU
AGAM
Dillon & Associates's Q4 2019 Portfolio in Review
As of Q4 2019, Dillon & Associates held 70 positions worth $357M, up 8.8% from $329M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Dillon & Associates's Q4 2019 filing shows 3 new, 33 increased, 21 reduced and 2 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,684 shares worth $364K. The largest sale was United Parcel Service, an estimated $1.65M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.
- Dillon & Associates's largest Q4 2019 buy was Bristol-Myers Squibb: 5,684 shares worth $364K.
- Dillon & Associates added most to Amazon in Q4 2019, an estimated $1.01M increase.
- Dillon & Associates's biggest Q4 2019 reduction was United Parcel Service, cutting an estimated $1.65M.
- Dillon & Associates fully exited Cognizant in Q4 2019, selling an estimated $355K.
- Dillon & Associates's ten largest holdings make up 47% of its $357M portfolio in Q4 2019.
- Dillon & Associates opened 3 new positions and closed 2 in Q4 2019.
- Dillon & Associates's portfolio value rose 8.8% quarter-over-quarter to $357M.
Based on Dillon & Associates's 13F filing for Q4 2019, filed 3 Feb 2020.